Kayne Anderson Rudnick Investment Management LLC Charles River Laboratories International, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

  • $39.8 Billion
  • Q2 2025

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 90 shares of CRL stock, worth $13,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 1,950,273 100.0%
Holding current value
$13,747
Previous $294 Million 100.0%
% of portfolio
0.0%
Previous 0.75%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$99.75 - $151.89 $195 Million - $296 Million
-1,950,183 Reduced 100.0%
90 $13,000
Q1 2025

May 14, 2025
BUY
$150.52 - $190.14 $21.8 Million - $27.5 Million
144,732 Added 8.02%
1,950,273 $294 Million
Q4 2024

Feb 13, 2025
SELL
$178.58 - $220.69 $24 Million - $29.6 Million
-134,284 Reduced 6.92%
1,805,541 $333 Million
Q3 2024

Nov 13, 2024
BUY
$187.96 - $245.29 $5.8 Million - $7.56 Million
30,836 Added 1.62%
1,939,825 $382 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $6.47 Million - $8.43 Million
31,359 Added 1.67%
1,908,989 $394 Million
Q1 2024

May 14, 2024
BUY
$203.52 - $273.43 $25.3 Million - $34 Million
124,392 Added 7.09%
1,877,630 $509 Million
Q4 2023

Feb 13, 2024
BUY
$164.52 - $238.84 $1.17 Million - $1.7 Million
7,137 Added 0.41%
1,753,238 $414 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $12.6 Million - $14.1 Million
64,981 Added 3.87%
1,746,101 $342 Million
Q2 2023

Aug 11, 2023
BUY
$183.71 - $210.25 $9.69 Million - $11.1 Million
52,757 Added 3.24%
1,681,120 $353 Million
Q1 2023

May 16, 2023
BUY
$191.89 - $259.92 $2.22 Million - $3.01 Million
11,563 Added 0.72%
1,628,363 $329 Million
Q4 2022

Feb 13, 2023
SELL
$197.11 - $250.07 $3.05 Million - $3.87 Million
-15,461 Reduced 0.95%
1,616,800 $352 Million
Q3 2022

Nov 16, 2022
BUY
$182.44 - $250.54 $298 Million - $409 Million
1,632,261 New
1,632,261 $321 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $294 Million - $403 Million
-1,609,827 Closed
0 $321 Million
Q2 2022

Aug 12, 2022
SELL
$204.13 - $302.4 $5.89 Million - $8.73 Million
-28,856 Reduced 1.76%
1,609,827 $344 Million
Q1 2022

May 16, 2022
BUY
$255.51 - $362.11 $22 Million - $31.2 Million
86,028 Added 5.54%
1,638,683 $465 Million
Q4 2021

Feb 14, 2022
BUY
$351.38 - $448.68 $24.9 Million - $31.8 Million
70,850 Added 4.78%
1,552,655 $585 Million
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $31.6 Million - $38.8 Million
84,769 Added 6.07%
1,481,805 $611 Million
Q2 2021

Aug 13, 2021
BUY
$294.17 - $371.65 $39.9 Million - $50.4 Million
135,717 Added 10.76%
1,397,036 $517 Million
Q1 2021

May 17, 2021
BUY
$249.67 - $299.48 $42.3 Million - $50.8 Million
169,486 Added 15.52%
1,261,319 $366 Million
Q4 2020

Feb 12, 2021
BUY
$222.0 - $252.62 $32.3 Million - $36.7 Million
145,362 Added 15.36%
1,091,833 $273 Million
Q3 2020

Nov 16, 2020
BUY
$175.56 - $226.45 $27 Million - $34.8 Million
153,828 Added 19.41%
946,471 $214 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $17.2 Million - $27.5 Million
145,047 Added 22.4%
792,643 $138 Million
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $55.9 Million - $101 Million
-565,314 Reduced 46.61%
647,596 $81.7 Million
Q4 2019

Feb 13, 2020
BUY
$126.05 - $152.76 $11 Million - $13.4 Million
87,523 Added 7.78%
1,212,910 $185 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $83.5 Million - $95.9 Million
667,611 Added 145.84%
1,125,387 $149 Million
Q2 2019

Aug 14, 2019
BUY
$123.4 - $148.55 $13.8 Million - $16.7 Million
112,229 Added 32.48%
457,776 $65 Million
Q1 2019

Jun 12, 2019
SELL
$104.82 - $146.73 $452,507 - $633,433
-4,317 Reduced 1.23%
345,547 $50.2 Million
Q1 2019

May 10, 2019
BUY
$104.82 - $146.73 $5.14 Million - $7.19 Million
49,035 Added 16.3%
349,864 $50.8 Million
Q4 2018

Feb 06, 2019
SELL
$105.09 - $137.23 $471,749 - $616,025
-4,489 Reduced 1.47%
300,829 $34 Million
Q3 2018

Nov 13, 2018
BUY
$112.11 - $134.54 $34.2 Million - $41.1 Million
305,318 New
305,318 $41.1 Million

Others Institutions Holding CRL

# of Institutions
614
Shares Held
56.7M
Call Options Held
1.41M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.77B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email